Cargando…
Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells
“Combination therapy”, which is a treatment modality combining two or more therapeutic agents, is considered a cornerstone of cancer therapy. The combination of anticancer drugs, of which functions are different from the other, enhances the efficiency compared to the monotherapy because it targets c...
Autores principales: | Nawara, Hend M., Afify, Said M., Hassan, Ghmkin, Zahra, Maram H., Atallah, Marwa N., Mansour, Hager, Abu Quora, Hagar A., Alam, Md Jahangir, Osman, Amira, Kakuta, Hiroki, Hamada, Hiroki, Seno, Akimasa, Seno, Masaharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352607/ https://www.ncbi.nlm.nih.gov/pubmed/32466563 http://dx.doi.org/10.3390/cancers12061360 |
Ejemplares similares
-
Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
por: Nawara, Hend M., et al.
Publicado: (2021) -
Metastasis of Cancer Stem Cells Developed in the Microenvironment of Hepatocellular Carcinoma
por: Afify, Said M., et al.
Publicado: (2019) -
Hematopoietic Cells Derived from Cancer Stem Cells Generated from Mouse Induced Pluripotent Stem Cells
por: Hassan, Ghmkin, et al.
Publicado: (2019) -
Differentiation of cancer stem cells into erythroblasts in the presence of CoCl(2)
por: Kumon, Kazuki, et al.
Publicado: (2021) -
GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation
por: Hassan, Ghmkin, et al.
Publicado: (2023)